BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 29294207)

  • 1. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
    Stang A; Jöckel KH; Heidinger O
    Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic skin cancer screening in Northern Germany.
    Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
    J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
    Eisemann N; Waldmann A; Holleczek B; Katalinic A
    J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma mortality following skin cancer screening in Germany.
    Boniol M; Autier P; Gandini S
    BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.
    Eisemann N; Waldmann A; Garbe C; Katalinic A
    Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
    Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
    Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
    Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
    Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The many unanswered questions related to the German skin cancer screening programme.
    Stang A; Garbe C; Autier P; Jöckel KH
    Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
    Katalinic A; Eisemann N; Waldmann A
    Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Wernli KJ; Henrikson NB; Morrison CC; Nguyen M; Pocobelli G; Blasi PR
    JAMA; 2016 Jul; 316(4):436-47. PubMed ID: 27458949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
    Eisemann N; Waldmann A; Katalinic A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
    Trautmann F; Meier F; Seidler A; Schmitt J
    Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of a population-based skin cancer screening program: evidence from Germany.
    Kaiser M; Schiller J; Schreckenberger C
    Eur J Health Econ; 2018 Apr; 19(3):355-367. PubMed ID: 28353004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.
    Katalinic A; Waldmann A; Weinstock MA; Geller AC; Eisemann N; Greinert R; Volkmer B; Breitbart E
    Cancer; 2012 Nov; 118(21):5395-402. PubMed ID: 22517033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma screening: Informing public health policy with quantitative modelling.
    Gilmore S
    PLoS One; 2017; 12(9):e0182349. PubMed ID: 28945758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma screening: A plan for improving early detection.
    Shellenberger R; Nabhan M; Kakaraparthi S
    Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.